[go: up one dir, main page]

WO1997039122A3 - PHOSPHOPROTEINE DE 78 kDa ISOLEE ET CLONEE DE MASTOCYTES (AGENT INHIBITEUR DE LA DEGRANULATION DES MASTOCYTES) ET SON UTILISATION - Google Patents

PHOSPHOPROTEINE DE 78 kDa ISOLEE ET CLONEE DE MASTOCYTES (AGENT INHIBITEUR DE LA DEGRANULATION DES MASTOCYTES) ET SON UTILISATION Download PDF

Info

Publication number
WO1997039122A3
WO1997039122A3 PCT/US1997/006042 US9706042W WO9739122A3 WO 1997039122 A3 WO1997039122 A3 WO 1997039122A3 US 9706042 W US9706042 W US 9706042W WO 9739122 A3 WO9739122 A3 WO 9739122A3
Authority
WO
WIPO (PCT)
Prior art keywords
mast cell
moesin
protein
mast
cell degranulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/006042
Other languages
English (en)
Other versions
WO1997039122A9 (fr
WO1997039122A2 (fr
Inventor
Theoharis C Theoharides
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MURO PHARMACEUTICAL Inc
Original Assignee
MURO PHARMACEUTICAL Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MURO PHARMACEUTICAL Inc filed Critical MURO PHARMACEUTICAL Inc
Priority to AU24563/97A priority Critical patent/AU2456397A/en
Publication of WO1997039122A2 publication Critical patent/WO1997039122A2/fr
Publication of WO1997039122A3 publication Critical patent/WO1997039122A3/fr
Publication of WO1997039122A9 publication Critical patent/WO1997039122A9/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

On a cloné une protéine de mastocyte de 78 kDa (moesine) depuis le rat et on a déterminé son ADNc et sa séquence d'acides aminés. Cette protéine est phosphorylée sur des résidus spécifiques de serine et de threonine sous l'effet exercé dans les mastocytes par un ou plusieurs isozymes de protéine kinase C, en particulier, l'isozyme κ, ce qui permet d'obtenir une phosphoprotéine qui inhibe la dégranulation des mastocytes (agent inhibiteur de la dégranulation des mastocytes). On peut stimuler la phosphorylation in vivo de cette protéine dans les mastocytes au moyen de médicaments, tels que cromolyne, nedocromil, de flavonoïdes, tels que quercetine et kaempherol, et de lodoxamide, On peut inhiber la dégranulation des mastocytes au moyen de l'administration d'inhibiteurs de phosphomoesine phosphatase. On peut identifier des tissus déficients en moesine de mastocytes au moyen d'un anticorps marqué anti-moesine ou anti-phosphomoesine et les traiter au moyen de la transfection de ces mastocytes par de l'ADNc de moesine dans un vecteur viral, tel que le vecteur du virus de la grippe.
PCT/US1997/006042 1996-04-12 1997-04-11 PHOSPHOPROTEINE DE 78 kDa ISOLEE ET CLONEE DE MASTOCYTES (AGENT INHIBITEUR DE LA DEGRANULATION DES MASTOCYTES) ET SON UTILISATION Ceased WO1997039122A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU24563/97A AU2456397A (en) 1996-04-12 1997-04-11 Isolated and cloned mast cell 78 kda phosphoprotein (mast cell degranulation inhibitory agent) and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63118496A 1996-04-12 1996-04-12
US08/631,184 1996-04-12

Publications (3)

Publication Number Publication Date
WO1997039122A2 WO1997039122A2 (fr) 1997-10-23
WO1997039122A3 true WO1997039122A3 (fr) 1997-12-24
WO1997039122A9 WO1997039122A9 (fr) 1998-03-26

Family

ID=24530125

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/006042 Ceased WO1997039122A2 (fr) 1996-04-12 1997-04-11 PHOSPHOPROTEINE DE 78 kDa ISOLEE ET CLONEE DE MASTOCYTES (AGENT INHIBITEUR DE LA DEGRANULATION DES MASTOCYTES) ET SON UTILISATION

Country Status (2)

Country Link
AU (1) AU2456397A (fr)
WO (1) WO1997039122A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280739B1 (en) * 1996-04-18 2001-08-28 Genetics Institute, Inc. Method of inhibiting angiogenesis using secreted proteins
US5872234A (en) 1997-06-27 1999-02-16 Incyte Pharmaceuticals, Inc. Human extracellular matrix proteins
EP1557426A3 (fr) * 1998-02-09 2005-08-03 Human Genome Sciences, Inc. 45 Protéines humaines secrétées
KR20010043088A (ko) * 1998-04-28 2001-05-25 우에노 도시오 신규인 폴리펩티드, 그 폴리펩티드를 코드화하는 ｃＤＮＡ및 그 용도
US8410248B2 (en) 1999-03-12 2013-04-02 Human Genome Sciences Inc. HWBAO62 polypeptides
MXPA01012181A (es) * 1999-05-28 2002-07-22 Zymogenetics Inc Proteina-31 alfa-helicoidal secretada.
US7893218B2 (en) * 2003-06-16 2011-02-22 Stowers Institute For Medical Research Antibodies that specifically bind SOST peptides
RU2380100C1 (ru) * 2008-08-27 2010-01-27 Научно-исследовательский институт гриппа Северо-Западного отделения Российской академии медицинских наук (НИИ гриппа СЗО РАМН) Средство для профилактики и лечения гриппа а и в

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0613945A2 (fr) * 1993-02-25 1994-09-07 The General Hospital Corporation Merlin, gène suppresseur de tumeurs, et ses utilisations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0613945A2 (fr) * 1993-02-25 1994-09-07 The General Hospital Corporation Merlin, gène suppresseur de tumeurs, et ses utilisations

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
LANKES WT ET AL: "Moesin: a member of the protein 4.1-talin-ezrin family of proteins.", PROC NATL ACAD SCI U S A, OCT 1 1991, 88 (19) P8297-301, UNITED STATES, XP002045604 *
NAKAMURA F ET AL: "Phosphorylation of threonine 558 in the carboxyl-terminal actin-binding domain of moesin by thrombin activation of human platelets.", J BIOL CHEM, DEC 29 1995, 270 (52) P31377-85, UNITED STATES, XP002045605 *
SATO N ET AL: "A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites.", J CELL SCI, SEP 1992, 103 ( PT 1) P131-43, ENGLAND, XP002045603 *
SCHWARTZ-ALBIEZ R ET AL: "Differential expression of the microspike-associated protein moesin in human tissues.", EUR J CELL BIOL, JUL 1995, 67 (3) P189-98, GERMANY, XP002045606 *

Also Published As

Publication number Publication date
AU2456397A (en) 1997-11-07
WO1997039122A2 (fr) 1997-10-23

Similar Documents

Publication Publication Date Title
Scott et al. Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase.
Desautels et al. Demonstration of an ATP-dependent, vanadate-sensitive endoprotease in the matrix of rat liver mitochondria.
EP1449834A3 (fr) Inhibition de raf kinase au moyen de diphenylurées substituées symetriques et asymetriques
CA2359510A1 (fr) Diphenylurees a substituants .omega.-carboxyaryles, inhibitrices de kinase raf
NO20040222L (no) Peptider til fjerning eller destruksjon av celler
GEP20032976B (en) Artificial Peptides Having Surface Activity and Use Thereof in The Preparation of Artificial Surfactant
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
EP2014678A3 (fr) Peptides KDR et vaccins les comportant
CA2180950A1 (fr) Proteines de "domaine de kunitz" a activite antikallikreine, et leurs analogues
WO1997039122A3 (fr) PHOSPHOPROTEINE DE 78 kDa ISOLEE ET CLONEE DE MASTOCYTES (AGENT INHIBITEUR DE LA DEGRANULATION DES MASTOCYTES) ET SON UTILISATION
AU636148B2 (en) Human leukocyte elastase inhibitors
Janoff et al. Digestion of lung proteins by human leukocyte granules in vitro
DK0662948T3 (da) 2-amino-4-phenyl-4-oxosmørsyrederivater med kynureninase- og/eller kynurenin-3-hydroxylaseinhiberende virkning
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
Prasa et al. Inhibition of thrombin generation in plasma by inhibitors of factor Xa
WO2002062304A3 (fr) Agents cosmetiques et/ou pharmaceutiques
WO1999009199A3 (fr) Facteur d'elongation-2 kinase(ef-2 kinase) et ses procedes d'utilisation
Nishiura et al. A high molecular weight inhibitor of Ca2+-dependent neutral protease in rat brain
EP0676469A3 (fr) Facteur de transcription APRF
Sudilovsky In vivo regulation of hepatic protein kinase by adenosine 3′, 5′-monophosphate mediated glucagon stimulation
NO307403B1 (no) Fremgangsmåte for tørr fremstilling av partikler, tørrfremstilte partikler oppnådd på denne måte, samt farmasøytiske blandinger som inneholder slike partikler
CA2388180A1 (fr) Inhibiteurs de la molecule d'inositol polyphosphate 5-phosphatase ship2
MY126962A (en) A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
EP0391400A3 (fr) Procédé de stabilisation du précurseur de l'urokinase et préparation desséchée
DK270489D0 (da) Protein med thrombininhiberende virkning, fremgangsmaade til dets isolering, samt dets anvendelse som laegemiddel

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
COP Corrected version of pamphlet

Free format text: PAGES 1-106, DESCRIPTION, REPLACED BY CORRECT PAGES 1-44; PAGES 107-128, CLAIMS, REPLACED BY CORRECT PAGES 45-47; PAGES 1/10-10/10, DRAWINGS, REPLACED BY CORRECT PAGES 1/5-5/5

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97537233

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase